أفضل جراحو الزرع في Пекин - توب -5 أطباء

Dr. Xiao Juan is a specialist at the clinic and Chief Physician/Ward Director of Ward 9 in the Hematology Oncology Center at Beijing Jingdu Children’s Hospital. With nearly 20 years of clinical experience, she focuses on HSCT and cellular immunotherapy for refractory childhood blood diseases, including refractory acute B lymphoblastic leukemia. Her differentiator includes academic recognition—an Excellent Paper Award at the 28th National Academic Conference on Pediatrics of the Chinese Medical Association for refractory acute B lymphoblastic leukemia in children.

Dr. Huang Liuming is a specialist at the clinic and a chief physician at Beijing Jingdu Children’s Hospital. He focuses on minimally invasive pediatric surgery and pediatric liver transplantation, with nearly 30 years of experience since around 1995. His differentiator is that around 2005 he led development of minimally invasive treatment for pediatric surgery and pediatric liver transplantation in China, supported by advanced training at the University of Innsbruck and Queen Mary Hospital (University of Hong Kong).

Dr. Jiang Fan is a specialist at the clinic and an Associate Chief Physician in the Department of Hematology at Beijing Jingdu Children’s Hospital. She focuses on pediatric hematology with particular experience in hematopoietic stem cell transplantation and childhood immunodeficiency diseases. Her differentiator is transplant-related expertise including umbilical cord blood combined with peripheral stem cell co-transfusion technology, alongside experience in chronic active EB virus infection.

Dr. Liu Zhouyang is a specialist at the clinic and Chief Physician/Director of the Hematology Inpatient Ward at Beijing Jingdu Children’s Hospital. With over 15 years of experience, he manages high-risk pediatric blood disorders including CAEBV and refractory HLH. His differentiator is protocol leadership for infant HSCT: he led the 2024 Chinese Expert Consensus on Infant HSCT Procedures, adopted by over 30 transplant centers, and created a national long-term follow-up database for n=326 infant transplants.

Professor Sun Yuan is a specialist at the clinic and a pediatric hematology specialist with nearly 30 years of clinical experience. She pioneered China’s first autologous cord blood transplant for severe aplastic anemia (2009) and improved primary HLH outcomes by shifting HSCT to the first remission phase, reporting 5-year survival of 70%–80%. Her differentiator is full-cycle transplant management: she developed a “1000-Day Post-Transplantation Management Model” with immune monitoring starting 3 months after surgery and early rhGH therapy for growth hormone deficiency.